CPLX2是一种新型抑癌基因并改善胶质瘤预后
研究利用TCGA和CGGA数据库分析CPLX2在胶质瘤中的表达,并通过RT-qPCR检测68例随访胶质瘤患者,结合Kaplan-Meier生存分析及体外和异种移植实验,发现CPLX2表达下调且与胶质瘤分级负相关,高表达预示更长生存,过表达抑制肿瘤发生,敲低促进细胞增殖,GSEA和共表达分析提示其可能通过缺氧和炎症通路影响恶性程度。
要点
- CPLX2在胶质瘤中表达下调,且与胶质瘤分级呈负相关。
- CPLX2高表达预示胶质瘤患者更长生存。
- 过表达CPLX2在体内外抑制肿瘤发生,敲低则促进胶质瘤细胞增殖。
核心结论
- CPLX2发挥抑癌基因功能,可作为胶质瘤潜在的预后标志物。
研究设计与样本
- 从TCGA和CGGA数据库下载胶质瘤转录组数据进行分析,并通过RT-qPCR检测68例随访胶质瘤患者的CPLX2表达。
- 构建CPLX2敲低和过表达的细胞系,进行细胞生长、集落形成和异种移植肿瘤形成实验。
主要发现
- CPLX2在胶质瘤中表达下调,且与胶质瘤分级呈负相关。
- Kaplan-Meier生存曲线分析显示,CPLX2高表达预示更长的生存期。
- 过表达CPLX2在体内和体外均削弱胶质瘤进展中的肿瘤发生。
- 敲低CPLX2促进胶质瘤细胞增殖。
- GSEA和共表达分析揭示CPLX2可能通过调控缺氧和炎症通路影响胶质瘤恶性程度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioma is a type of malignant cancer that affect the central nervous system. New predictive biomarkers have been investigated in recent years, but the clinical prognosis for glioma remains poor. The function of CPLX2 in glioma and the probable molecular mechanism of tumor suppression were the focus of this investigation. METHODS: The glioma transcriptome profile was downloaded from The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases for analysis of CPLX2 expression in glioma. RT-qPCR was performed to detect the expression of CPLX2 in 68 glioma subjects who have been followed up. Kaplan-Meier survival analyses were conducted to assess the effect of CPLX2 on the prognosis of glioma patients. The knockdown and overexpressed cell lines of CPLX2 were constructed to investigate the impact of CPLX2 on glioma. The cell growth, colony formation, and tumor formation in xenograft were performed. RESULTS: The expression of CPLX2 was downregulated in glioma and was negatively correlated with the grade of glioma. The higher expression of CPLX2 predicted a longer survival, as indicated by the analysis of Kaplan-Meier survival curves. Overexpressed CPLX2 impaired tumorigenesis in glioma progression both in vivo and in vitro. Knocking down CPLX2 promoted the proliferation of glioma cells. The analysis of GSEA and co-expression analysis revealed that CPLX2 may affect the malignancy of glioma by regulating the hypoxia and inflammation pathways. CONCLUSIONS: Our data indicated that CPLX2 functions as a tumor suppressor and could be used as a potential prognostic marker in glioma.
引用
- Chen Y, Ning J, Shu L, et al. CPLX2 is a novel tumor suppressor and improves the prognosis in glioma. J Neurooncol. 2024. PMID: 38427133. doi:10.1007/s11060-023-04548-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。